RESUMEN
Intestinal microbiome perturbation characterizes Crohn's disease (CD), though specific contributors to pathophysiology remain elusive. In a recent issue of Science, Jain et al. show that Debaryomyces hansenii impairs intestinal healing in mice via effects on type I interferon signaling and chemokine CCL5 expression in macrophages and that it is also prevalent in the inflamed mucosa of CD patients.
Asunto(s)
Enfermedad de Crohn/inmunología , Enfermedad de Crohn/microbiología , Mucosa Intestinal/microbiología , Cicatrización de Heridas/inmunología , Animales , Quimiocina CCL5/inmunología , Microbioma Gastrointestinal/inmunología , Humanos , Interferón Tipo I/inmunología , Mucosa Intestinal/inmunología , Macrófagos/inmunología , Ratones , Micosis/inmunología , Micosis/microbiología , Saccharomycetales/inmunología , Transducción de Señal/inmunologíaRESUMEN
Alterations of the mycobiota composition associated with Crohn's disease (CD) are challenging to link to defining elements of pathophysiology, such as poor injury repair. Using culture-dependent and -independent methods, we discovered that Debaryomyces hansenii preferentially localized to and was abundant within incompletely healed intestinal wounds of mice and inflamed mucosal tissues of CD human subjects. D. hansenii cultures from injured mice and inflamed CD tissues impaired colonic healing when introduced into injured conventionally raised or gnotobiotic mice. We reisolated D. hansenii from injured areas of these mice, fulfilling Koch's postulates. Mechanistically, D. hansenii impaired mucosal healing through the myeloid cell-specific type 1 interferon-CCL5 axis. Taken together, we have identified a fungus that inhabits inflamed CD tissue and can lead to dysregulated mucosal healing.
Asunto(s)
Enfermedad de Crohn/microbiología , Enfermedad de Crohn/patología , Debaryomyces/aislamiento & purificación , Debaryomyces/fisiología , Mucosa Intestinal/microbiología , Mucosa Intestinal/patología , Anfotericina B/farmacología , Animales , Antibacterianos/farmacología , Antifúngicos/farmacología , Quimiocina CCL5/metabolismo , Colon/microbiología , Colon/patología , Enfermedad de Crohn/inmunología , Debaryomyces/crecimiento & desarrollo , Femenino , Microbioma Gastrointestinal , Vida Libre de Gérmenes , Humanos , Íleon/microbiología , Íleon/patología , Inflamación , Interferón Tipo I/metabolismo , Mucosa Intestinal/inmunología , Macrófagos/inmunología , Macrófagos/microbiología , Masculino , Ratones , Ratones Endogámicos C57BLRESUMEN
Recent data using improved cultural, molecular, and serological techniques have strengthened the association of Mycobacterium paratuberculosis with Crohn's disease, an inflammatory bowel disease (IBD) with unknown etiology. To provide more evidence of an etiological association, antibody reactivities of Crohn's disease patients were tested by immunoblotting against M. paratuberculosis-recombinant antigens. A clone containing a 1,402-bp insert and expressing a 36K-antigen (p36) was analyzed. No homology was found between the deduced amino acid sequence of p36 and any protein sequences compiled in the GenBank indicating that p36 is a novel mycobacterial protein. The reactivity of 199 serum samples was tested against the p36 by immunoblotting technique. Sera from 77 of 89 (86.5%) Crohn's disease patients and 16 of 18 (89%) sera from patients with tuberculosis and leprosy reacted with p36 compared to 5 of 42 (12%) ulcerative colitis and non-IBD control sera (p < 0.0001). In addition, p36 reacted to all sera from 10 normal controls that were Bacillus Calmette-Guerin (BCG)-immunized and only to 10% of 40 normal controls that were not BCG-immunized. The fact that sera from Crohn's disease patients reacted to p36 with the same high frequency as the sera from patients that were exposed to mycobacterial antigens further supports the hypothesis of the mycobacterial etiology in Crohn's disease.
Asunto(s)
Anticuerpos Antibacterianos/sangre , Antígenos Bacterianos/genética , Antígenos Bacterianos/inmunología , Enfermedad de Crohn/inmunología , Mycobacterium avium subsp. paratuberculosis/inmunología , Antígenos Bacterianos/metabolismo , ADN Bacteriano/genética , Electroforesis en Gel de Poliacrilamida , Humanos , Immunoblotting , Lepra/inmunología , Datos de Secuencia Molecular , Proteínas Recombinantes/inmunología , Análisis de Secuencia de ADN , Tuberculosis/inmunologíaAsunto(s)
Anticuerpos Antibacterianos/sangre , Antígenos Bacterianos/genética , Antígenos Bacterianos/inmunología , Antígenos Bacterianos/metabolismo , Análisis de Secuencia de ADN , ADN Bacteriano/genética , Enfermedad de Crohn/inmunología , Electroforesis en Gel de Poliacrilamida , Lepra/inmunología , Immunoblotting , Mycobacterium avium subsp. paratuberculosis/inmunología , Proteínas Recombinantes/inmunología , Tuberculosis/inmunologíaRESUMEN
Mycobacterium paratuberculosis is the causative agent of Johne's disease, a chronic enteritis in ruminants. It has also been implicated as a possible cause of Crohn's disease, an inflammatory bowel disease of unknown etiology. The mycobacterial 65K heat shock proteins (hsp-65K) are among the most extensively studied mycobacterial proteins, and their immunogenic characteristics have been suggested to be the basis for autoimmunization in chronic inflammatory diseases. In this context, we isolated and sequenced the hsp-65K-encoding gene from our M. paratuberculosis PTB65K genomic library. A high degree of identity was found between the open reading frame (ORF) of the PTB65K gene and those of Mycobacterium tuberculosis (89.6%), Mycobacterium leprae (86.6%), and Mycobacterium avium 18 (98.8%). The amino acid sequence alignment of the PTB65K protein with the hsp-65K homologs revealed that the M. tuberculosis and M. leprae proteins each differed by 36 amino acid residues and that the M. avium 18 protein differed by 8 residues. We also investigated the humoral immune responses of animals with Johne's disease and patients with Crohn's disease against the recombinant PTB65K antigen. Immunoblot analysis showed that sera from only 3 of 10 clinically ill and 5 of 25 subclinically ill cows reacted with PTB65K. In addition, sera from two of two sheep and one of two goats with clinical symptoms of Johne's disease also reacted with PTB65K; 0 samples from 10 normal cows reacted. In humans, sera from 7 of 13 patients with Crohn's disease, 3 of 4 with tuberculosis, 5 of 6 with leprosy, 5 of 12 with non-inflammatory bowel disease, and 0 of 4 with ulcerative colitis reacted with the recombinant PTB65K antigen. These results indicate that this PTB65K heat shock protein is uninformative when used for serodiagnosis of Johne's disease in animals. However, in humans, the high intensity of antibody reactions of some sera from Crohn's disease patients compared with that from noninflammatory bowel disease patients showed a positive correlation with mycobacterial diseases.
Asunto(s)
Proteínas de Choque Térmico/genética , Proteínas de Choque Térmico/inmunología , Mycobacterium avium subsp. paratuberculosis/genética , Mycobacterium avium subsp. paratuberculosis/inmunología , Animales , Anticuerpos Antibacterianos/inmunología , Secuencia de Bases , Bovinos , Clonación Molecular , Enfermedad de Crohn/inmunología , Enfermedad de Crohn/microbiología , Genes Bacterianos/genética , Cabras , Humanos , Datos de Secuencia Molecular , Paratuberculosis/inmunología , Paratuberculosis/microbiología , Conejos , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido , OvinosAsunto(s)
Bovinos , Conejos , Anticuerpos Antibacterianos/inmunología , Análisis de Secuencia de ADN , Clonación Molecular , Datos de Secuencia Molecular , Enfermedad de Crohn/inmunología , Enfermedad de Crohn/microbiología , Genes Bacterianos/genética , Homología de Secuencia de Aminoácido , Mycobacterium tuberculosis/inmunología , Paratuberculosis/genética , Paratuberculosis/inmunología , Secuencia de BasesRESUMEN
Members of the Mycobacterium avium-Mycobacterium intracellulare (MAI) complex are typeable because each serovar is characterized by its own specific antigenic glycolipid. By means of an enzyme-linked immunosorbent assay, we studied serum specimens obtained from 148 healthy college students for antibodies to these glycopeptidolipids. Ninety-two (61.5%) of the serum specimens were positive to the specific glycolipid antigen from MAI serovar 8. In a study of a pediatric population, antibodies appeared to develop during adolescence. Individuals with overt mycobacterial disease had a significantly lower incidence (tuberculosis patients, 34.5%; leprosy patients, 25%). We found a lower incidence of positive results in a survey of 96 Japanese serum specimens (29.1%), but the results from a survey of sera obtained from Bombay, India, indicated a large degree of reactivity (55.5%). Antibodies to other MAI serovars (serovars 2, 4, and 11) were not found, except antibodies to MAI serovar 21 were seen in the same individuals with antibodies to serovar 8. The dominant epitope of the MAI serovar 8-specific glycopeptidolipid is a terminal pyruvylated 3-O-methylglucose residue [4,6-(1'-carboxyethylidene)-3-O-methyl-alpha-D-glucopyranosyl] unit, whereas that of the MAI serovar 21 has the same terminal pyruvylated glucose devoid of the 3-methoxy group. Thus the antibodies appear specific for the pyruvylated glucose. It is unclear whether the high prevalence of antibodies to these epitopes reflects a high incidence of subclinical colonization or infection with certain MAI serovars or whether they are acquired through contact with some other related antigen source.
Asunto(s)
Anticuerpos Antibacterianos/análisis , Glucolípidos/inmunología , Complejo Mycobacterium avium/inmunología , Piruvatos/inmunología , Animales , Enfermedad de Crohn/inmunología , Humanos , Ácido Pirúvico , Conejos , Relación Estructura-ActividadRESUMEN
The proportion of oligosaccharide chains on the Fc fragment of IgG which terminate with N-acetylglucosamine (GlcNAc) rather than galactose is increased in rheumatoid arthritis and tuberculosis, and in sera from patients with Crohn's disease, probably because of decreased activity of a galactosyltransferase in B lymphocytes. We have assayed the prevalence of agalactosyl oligosaccharides on IgG in sera from 67 patients with inflammatory bowel disease (32 ulcerative colitis and 35 Crohn's disease). The prevalence of agalactosyl IgG significantly increases in the majority of Crohn's patients (19/35 patients), and correlates with the level of C-reactive protein (r = 0.79), and inversely with the concentration of serum albumin. Sera from ulcerative colitis patients show less frequent (nine of 32) and less marked rises in agalactosyl IgG, and sera with high C-reactive protein values can contain normal levels. Thus in ulcerative colitis no correlation was seen between the two assays. The diseases in which the percentage of agalactosyl IgG is raised (rheumatoid arthritis, tuberculosis, Crohn's disease and some ulcerative colitis) are characterised by simultaneous T cell mediated granulomatous tissue damage, and acute phase responses. Levels are normal in less tissue damaging granulomatous conditions, including sarcoidosis, and leprosy (except during episodes of erythema nodosum leprosum). We suggest therefore that a raised percentage of agalactosyl IgG is a correlate of a particular type of T cell mediated pathology which may be relevant to the pathogenesis of inflammatory bowel disease.
Asunto(s)
Proteína C-Reactiva/análisis , Colitis Ulcerosa/inmunología , Enfermedad de Crohn/inmunología , Inmunoglobulina G/análisis , Adolescente , Adulto , Colitis Ulcerosa/sangre , Enfermedad de Crohn/sangre , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
In order to evaluate the role of mycobacteria in the pathogenesis of Crohn's disease (CD), 4 monoclonal antibodies (McAb's) raised against M. avium specific glycolipid were tested on bowel resection specimens of CD patients and relevant controls. Two of the McAb's had shown a positive reaction to a CD-Mycobacteria isolate (CD-Myc). The same two McAb's showed a positive reaction within the gut wall, not only in CD patients, but also in the controls. In non-CD controls, however, the positive cells were limited to the lamina propria, while in CD patients positivity was also found in the submucosa and subserosa. Furthermore the mean number of positive cells in CD patients tends to be higher than in the control groups. Using double staining techniques the positive cells appeared to be B-cells of IgA isotype. These preliminary results indicate that mycobacteria might play a role in the pathogenesis of Crohn's disease.